Searched for
BRISTOL MYERS
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Bristol Myers partners with Microsoft for AI-driven lung cancer detectionBristol Myers Squibb is joining forces with Microsoft. They will use artificial intelligence to find lung cancer earlier. This technology a...
- Syngene expands research collaboration with Bristol Myers SquibbSyngene International has extended its research partnership with Bristol Myers Squibb until 2035. This expanded agreement covers more servi...
- Biocon arm widens partnership terms with Bristol-Myers SquibbAs part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 sq ft of laboratory and office space for Bristo...
- Biocon’s unit extends partnership with US-based Bristol-Myers SquibbThe two cos announced to renew their engagement, boosted by encouraging results in last 5 years, during when 6 drug molecules have been bro...
- Bristol-Myers sues Dr Reddy's Laboratories for patent infringement in USBristol-Myers Squibb Company has filed patent infringement case against Dr Reddy's Laboratories over the cancer drug Ixempra.
- Biocon close to oral insulin deal with Bristol-Myers SquibbFour months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bri...
- Bristol-Myers Squibb to acquire Amylin for USD 5.3 billionBristol-Myers Squibb will acquire drug maker Amylin for USD 5.3 billion, a move that will strengthen its position in the diabetic medicines...
- Bristol-Myers offers $3.5 bn for Amylin: ReportsShares of Amylin Pharmaceuticals Inc rose as much as 51 percent as the company rejected a $3.5 billion unsolicited takeover bid from Bristo...
- Biocon's Syngene, Bristol-Myers Squibb open new R&D unitWhile current global economic slowdown has prompted many companies to cut down on their R&D spends and/or suspend research on certain molec...
- Bristol-Myers to sell medical imaging unitDrug developer Bristol-Myers Squibb said on Monday it will sell its medical imaging unit to private equity firm Avista Capital Partners for...
- Syngene signs agreement with Bristol-MyersBiocon’s subsidiary company Syngene said it has entered into a research partnership with Bristol-Myers Squibb.
- Biocon subsi ties up with Bristol-Myers SquibbIntegrated biotechnology firm Biocon on Wednesday said its subsidiary Syngene has entered into a research partnership with global pharma ma...
- Schering-Plough, Sanofi set sights on Bristol-MyersBristol-Myers Squibb, which fired its chief executive officer this week, may be targeted for takeover by Schering-Plough or French drugmake...
- Drugmakers eye Bristol-MyersSeveral of the world’s top drugmakers may weigh acquiring Bristol-Myers Squibb after it fired its chief executive, although suitors seem un...
- Bristol-Myers CEO in hot seat as board meet nearsPeter Dolan, Bristol-Myers Squibb’s embattled chief, spent his summer vacation in France cycling 350 miles in five days.
Load More
